Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple...

por Mateos, María-Victoria, Masszi, Tamas, Grzasko, Norbert, Hansson, Markus, Sandhu, Irwindeep, Pour, Ludek, Viterbo, Luísa, Jackson, Sharon R., Stoppa, Anne-Marie, Gimsing, Peter, Hamadani, Mehdi, Borsaru, Gabriela, Berg, Deborah, Lin, Jianchang, Di Bacco, Alessandra, van de Velde, Helgi, Richardson, Paul G., Moreau, Philippe
Publicado 2017